DEA Moves To Reclassify Marijuana As A Schedule III Drug

This Historic federal action would recognize medical benefits of cannabis, open the door for more research, and be a significant change for the industry.
United States Cannabis & Hemp
To print this article, all you need is to be registered or login on Mondaq.com.

This Historic federal action would recognize medical benefits of cannabis, open the door for more research, and be a significant change for the industry. Additionally rescheduling would lift the burden of 280E from legal cannabis operators. Regulatory change will involve notice and comment rulemaking - a potentially lengthy process - we will continue to follow as this develops.

US drug control agency will move to reclassify marijuana in a historic shift, AP sources say

apnews.com/...

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

DEA Moves To Reclassify Marijuana As A Schedule III Drug

United States Cannabis & Hemp

Contributor

See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More